Indoles (administration & dosage) < Indoles (adverse effects) < Indoles (diagnostic use)

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 24.
[0-20] [0 - 20][0 - 24][20-23][20-40]

Ident.	Authors (with country if any)	Title
000097 (1999)	J. Fine ; A E Lang	Dose-induced penile erections in response to ropinirole therapy for Parkinson's disease.
000217 (2000)	C W Olanow [États-Unis] ; A H Schapira ; T. Roth	Waking up to sleep episodes in Parkinson's disease.
000538 (2001)	E C Maratos [Royaume-Uni] ; M J Jackson ; R K Pearce ; P. Jenner	Antiparkinsonian activity and dyskinesia risk of ropinirole and L-DOPA combination therapy in drug naïve MPTP-lesioned common marmosets (Callithrix jacchus).
000712 (2002)	Paul Morrish [Royaume-Uni]	Is it time to abandon functional imaging in the study of neuroprotection?
000C26 (2003)	Michael P. Hill [Royaume-Uni] ; Erwan Bezard ; Steven G. Mcguire ; Alan R. Crossman ; Jonathan M. Brotchie ; Ann Michel ; Renee Grimée ; Henrik Klitgaard	Novel antiepileptic drug levetiracetam decreases dyskinesia elicited by L-dopa and ropinirole in the MPTP-lesioned marmoset.
000F67 (2004)	Katherine Grosset [Royaume-Uni] ; Fiona Needleman ; Graeme Macphee ; Donald Grosset	Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table.
000F82 (2004)	Yvonne Körner [Allemagne] ; Charlotte Meindorfner ; Jens Carsten Möller ; Karin Stiasny-Kolster ; Doris Haja ; Werner Cassel ; Wolfgang Hermann Oertel ; Hans-Peter Krüger	Predictors of sudden onset of sleep in Parkinson's disease.
001025 (2004)	Arthur S. Walters [États-Unis] ; William G. Ondo ; Tilman Dreykluft ; Ron Grunstein ; Daniel Lee ; Kapil Sethi	Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study.
001798 (2006)	Jacques Montplaisir [Canada] ; Jeff Karrasch ; Jean Haan ; Dieter Volc	Ropinirole is effective in the long-term management of restless legs syndrome: a randomized controlled trial.
001819 (2006)	Olivier Rascol [France] ; David J. Brooks ; Amos D. Korczyn ; Peter P. De Deyn ; Carl E. Clarke ; Anthony E. Lang ; Mona Abdalla	Development of dyskinesias in a 5-year trial of ropinirole and L-dopa.
001B12 (2007)	Carlos Singer [États-Unis] ; Janice Lamb ; Amanda Ellis ; Gary Layton	A comparison of sumanirole versus placebo or ropinirole for the treatment of patients with early Parkinson's disease.
001D65 (2007)	Yoshikuni Mizuno [Japon] ; Takashi Abe ; Kazuko Hasegawa ; Sadako Kuno ; Tomoyoshi Kondo ; Mitsutoshi Yamamoto ; Mitsuyoshi Nakashima ; Ichiro Kanazawa	Ropinirole is effective on motor function when used as an adjunct to levodopa in Parkinson's disease: STRONG study.
001E48 (2007)	Robert A. Hauser [États-Unis] ; Olivier Rascol ; Amos D. Korczyn ; A. Jon Stoessl ; Ray L. Watts ; Werner Poewe [Autriche] ; Peter P. De Deyn ; Anthony E. Lang	Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa.
002374 (2009)	Andrew H. Evans ; James R. Stegeman	Punding in patients on dopamine agonists for restless leg syndrome.
002505 (2009)	Frank Andersohn [Allemagne] ; Edeltraut Garbe	Cardiac and noncardiac fibrotic reactions caused by ergot-and nonergot-derived dopamine agonists.
002824 (2009)	Kelly E. Lyons [États-Unis] ; Rajesh Pahwa	An open-label conversion study of pramipexole to ropinirole prolonged release in Parkinson's disease.
002B67 (2010)	Ray L. Watts [États-Unis] ; Kelly E. Lyons ; Rajesh Pahwa ; Kapil Sethi ; Matthew Stern ; Robert A. Hauser ; Warren Olanow ; Alex M. Gray ; Bryan Adams ; Nancy L. Earl	Onset of dyskinesia with adjunct ropinirole prolonged-release or additional levodopa in early Parkinson's disease.
002C90 (2010)	Raffaella Di Giacopo ; Alfonso Fasano ; Riccardo Fenici ; Giovanna Loria ; Anna Rita Bentivoglio	Rare and serious cardiac side effects during ropinirole titration.
003101 (2011)	Fabrizio Stocchi [Italie] ; Luigi Giorgi ; Brian Hunter ; Anthony H V. Schapira	PREPARED: Comparison of prolonged and immediate release ropinirole in advanced Parkinson's disease.
003180 (2011)	Julia Grossac ; Stéphanie Ruiz ; Emmanuelle Bondon-Guitton ; Franck-Emmanuel Roux ; Olivier Fourcade ; Jean-Louis Montastruc ; Thomas Geeraerts	Severe intracranial bleeding related to vitamin K antagonist-ropinirole interaction.
003769 (2012)	Oliver Kaut ; Friedrich Asmus ; Sebastian Paus	Spontaneous unwelcome orgasms due to pramipexole and ropinirole.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Indoles (adverse effects)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Indoles (adverse effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Indoles (adverse effects)
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024